Literature DB >> 1278242

Dopamine metabolism in the nucleus accumbens: the effect of clozapine.

S Wilk, S D Glick.   

Abstract

Dopamine metabolism in the nucleus accumbens of the rat was studied by gas chromatographic quantitation of 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). The ratio of DOPAC/HVA in the nucleus accumbens was significantly greater than the same ratio in the striatum. Dose-response curves for the increase in DOPAC and HVA in the nucleus accumbens and striatum 2 h after clozapine were generated. The effect of clozapine on dopamine metabolism was similar in both structures.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1278242     DOI: 10.1016/0014-2999(76)90024-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action.

Authors:  T Ljungberg; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

Review 2.  Antidepressant and antipsychotic agents.

Authors:  R A Lahti
Journal:  Naturwissenschaften       Date:  1979-08

3.  Effect of D-amphetamine on the behaviour of rats in the open field apparatus: interaction with four neuroleptics and changes in biogenic amine metabolsm in discrete brain regions.

Authors:  M A Lynch; M Kenny; B E Leonard
Journal:  Ir J Med Sci       Date:  1978-10       Impact factor: 1.568

Review 4.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

5.  Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.

Authors:  C Köhler; L Haglund; S O Ogren; T Angeby
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.